Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Safety Study of Stemchymal® in Acute Liver Failure
Phase 1
Withdrawn
- Conditions
- Acute Liver FailureSteminentStem CellsAdult Stem CellsAcute-On-Chronic Liver Failure
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Steminent Biotherapeutics Inc.
- Registration Number
- NCT03629015
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee
Phase 1
Completed
- Conditions
- Osteoarthritis Knee
- Interventions
- Drug: Adipose-Derived Mesenchymal Stem Cells
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Steminent Biotherapeutics Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT02544802
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia
Phase 2
Completed
- Conditions
- Cerebellar Ataxia
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Steminent Biotherapeutics Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT02540655
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
News
No news found